
Reimbursement
Latest News
Latest Videos
CME Content
More News

A recent report highlights how Americans pay more for prescription drugs compared with other countries.

Less serious adverse events remain a concern for patients treated for chronic diseases.

Top news of the day from across the health care landscape.

Tisagenlecleucel (Kymriah) induced remission in a patient with acute lymphoblastic leukemia who was seemingly out of options.

Approximately 78% of survey respondents said that direct and indirect remuneration fees reduce the predictability of cash flow.

Top news of the day from across the health care landscape.

Pre-exposure prophylaxis is highly effective preventing HIV if used as prescribed.

Pharmacists rank fifth among the most honest and ethical professionals in the United States, according to the latest Gallup poll.

The risk of non-Hodgkin's lymphoma is elevated in patients with hepatitis C virus.

Chronic HCV infection has been linked to low serum zinc and low metallothioneins expression in liver cells.

Technology-driven customer intelligence and analytics allow specialty pharmacies to connect with patients before they drift from proper habits.

Identifying current deficiencies in clinical practice can help pinpoint care practices that can be implemented for cancer survivors.

Many factors influence whether a specialty pharmacy can gain access to limited distribution drug networks.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Patients with both hepatitis C and type 2 diabetes can develop fibrosis, steatosis, hepatocellular carcinoma, and resistance to antiviral treatment.

Participants in the Transform Rheumatoid Arthritis Care program could save 5% on drug spend.

A majority of patients with hepatitis C experience disorders outside of the liver that are related to the virus.

A combination VEGFR-2 inhibitor plus an anti–PD-L1 agent demonstrated antitumor activity in patients with previously treated advanced gastric or gastroesophageal junction adenocarcinoma.

Cabometyx found to improve median overall survival by 2.2 months in patients with previously treated advanced hepatocellular carcinoma.

The federal government previously ruled that dual eligibles would need to use the Medicare part D program for prescriptions preferentially.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, discusses what drove him to join the world of specialty pharmacy and the most rewarding part of it.

Automated HCV antigen testing has a much faster turnaround time and lower costs.

Important considerations for pharmacists to concerning the switch from a brand name biologic to a new biosimilar.

Health care organizations show support for proposed Medicare Part D rules that require direct and indirect remuneration fees to be included at the point-of-sale.